FDA Clearance Tracker · P130004-S008
ReSure Sealant
Last checked: Nov 20, 2026Latest source record: May 5, 2020 (this decision)Source: openFDAMethods & limitations
Decided
May 5, 2020
Approved
Time to decision
146 days
Received Dec 11, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P130004-S008
- Device name
- ReSure Sealant
- Applicant
- Ocular Therapeutix, Inc.
- Applicant location
- Bedford, MA
- Received
- Dec 11, 2019
- Decided
- May 5, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P130004
Device type
- Device type
- Ophthalmic Sealant (PFZ)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS), Device Exposure Registry Study.
Source documents
Other decisions for Ocular Therapeutix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.